European Market for Continuous Glucose Monitoring Systems

Despite its promising potential, industry participants are concerned about reimbursement and acceptance by conservative clinicians. However, the projected integration of continuous glucose monitoring systems with insulin pumps will support market expansion.

Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm, has found that the European continuous glucose monitoring systems market earned revenues of U.S.$14.0 million in 2006 and is likely to reach U.S.$30 million in 2009.

The biggest challenge facing market participants today is to devise a method of monitoring blood glucose levels that involves minimum or no discomfort to the patient. Technology initiatives are already underway to develop systems that offer reliable and accurate information on glucose levels. Companies need to produce affordable, user-friendly devices.

"Currently in the innovation stage of the product life cycle, the European continuous glucose monitoring systems market is witnessing considerable activity to quickly and effectively meet unmet demand,” said Aarati Ajay, a Frost & Sullivan industry analyst. "There are only three products available on the market and all of them are based on a model in which the sensors need to be changed every few days. Sensors are expensive and add significantly to the total cost of using the system.”

A number of large conglomerates as well as very small technology innovators have been attracted by the market's considerable potential.



Related Links:
Frost & Sullivan